snn0029
Small moleculeexperimental
Clinical trial activity
4 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2008 (NCT00800501)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- snn0029
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02269436 | Phase 1 | Jan 1, 2015 | Newron Pharmaceuticals |
| NCT01999803 | Phase 1 | Sep 1, 2014 | Katholieke Universiteit Leuven, Newron Pharmaceuticals, Utrecht University |
| NCT01384162 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2009 | ICON, Katholieke Universiteit Leuven, Medtronic, Newron Pharmaceuticals |
| NCT00800501 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2008 | ICON, Katholieke Universiteit Leuven, Medtronic, Newron Pharmaceuticals |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Newron Pharmaceuticals | For profit | 4 | 4 | 2 | 2008 |
| Katholieke Universiteit Leuven | Academic/Hospital | 3 | 0 | 2 | 2008 |
| ICON | For profit | 2 | 0 | 1 | 2008 |
| Medtronic | For profit | 2 | 0 | 1 | 2008 |
| Utrecht University | Academic/Hospital | 1 | 0 | 1 | 2014 |
5 organizations
Page 1 / 1